Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

'Statins in retinal disease'.

Ahmed Al-Janabi1,2, Sue Lightman3,4, Oren Tomkins-Netzer3,4,5

  • 1Moorfields Eye Hospital, London, UK. a.kasb@ucl.ac.uk.

Eye (London, England)
|March 21, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the impact of follow-up interval selection on the demand-capacity gap in ophthalmology.

Eye (London, England)·2026
Same author

Clinical characteristics and outcomes of intraocular inflammation following intravitreal faricimab for neovascular age-related macular degeneration: a single-centre retrospective study.

Eye (London, England)·2026
Same author

Selective decreases in regulatory B cell (Breg) subsets in active uveitis: IL-10+CD19+CD24hiCD38hiBreg in patients and B10 Breg in mice.

International immunology·2026
Same author

Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Response to 'Comment on: 'Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation".

Eye (London, England)·2026
Same author

Sex-Related Effects on the Clinical Presentation of Uveitis.

American journal of ophthalmology·2026
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
Same journal

Oculomics and the NHS: A UK opportunity to translate eye-derived biomarkers into population health.

Eye (London, England)·2026
Same journal

Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?

Eye (London, England)·2026
Same journal

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.

Eye (London, England)·2026
Same journal

"When the lens drew a continent: a cartographic clue to Alport syndrome".

Eye (London, England)·2026
Same journal

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Eye (London, England)·2026
See all related articles

Statins show potential in treating certain retinal diseases by modulating immune responses. They may reduce the risk and progression of conditions like uveitis and diabetic retinopathy, but evidence for age-related macular degeneration and retinal vein occlusion is inconsistent.

Area of Science:

  • Ophthalmology and Immunology
  • Pharmacology

Background:

  • Statins are widely prescribed for cholesterol reduction and cardiovascular disease.
  • Emerging research highlights statins' immunomodulatory effects, impacting pathways like inflammation and angiogenesis.
  • Immune system dysregulation is a key factor in various retinopathies.

Purpose of the Study:

  • To review the evidence for statins' therapeutic effects in retinal diseases.
  • To evaluate the relationship between statins and the pathophysiology of conditions including age-related macular degeneration, diabetic retinopathy, and uveitis.

Main Methods:

  • A comprehensive literature review of studies on statins and retinal diseases was performed.
  • PubMed database was searched for relevant research.

Related Experiment Videos

Main Results:

  • Statins show inconsistent effects in age-related macular degeneration (AMD), but may reduce choroidal neovascularization (CNV) risk.
  • No significant therapeutic benefit was found for statins in retinal vein occlusion.
  • Statins demonstrated a reduction in disease progression and improved outcomes in diabetic retinopathy, including diabetic macular edema (DMO).
  • Statins appear to have a protective effect against the development of uveitis.

Conclusions:

  • Statins exhibit potential therapeutic benefits in specific retinopathies, particularly diabetic retinopathy and uveitis, due to their immunomodulatory properties.
  • Further research is needed to clarify the role of statins in managing age-related macular degeneration and retinal vein occlusion.